Denver, Colorado (PRWEB) March 16, 2021 ValidCare, a leading provider of digital decentralized patient-centric clinical trials for the life science and
[co-authors: Heather Hatcher, Ph.D, and Lindsey Snyder]
It is no surprise that four in five Americans (86 percent) reportedly take dietary supplements to improve their overall health. Now more than ever, health consciousness is at the forefront – we are focused on improving our immune systems, specifically with an increased intake of readily accessible ingredients such as vitamins, minerals, herbs, amino acids, and enzymes, collectively known as dietary supplements. In the 27 years since Congress passed the Dietary Supplement Health and Education Act of 1994 ( DSHEA ), the US Food and Drug Administration (FDA) has had the authority to regulate dietary supplements; and, the FDA “plays an important role in helping consumers make use of safe, high-quality dietary supplements while also protecting Americans from the potential dangers of products that don’t meet the agency’s standards for marketing.”
Tuesday, March 2, 2021
It is no surprise that four in five Americans (86 percent) reportedly take dietary supplements to improve their overall health. Now more than ever, health consciousness is at the forefront – we are focused on improving our immune systems, specifically with an increased intake of readily accessible ingredients such as vitamins, minerals, herbs, amino acids, and enzymes, collectively known as dietary supplements. In the 27 years since Congress passed the Dietary Supplement Health and Education Act of 1994 ( DSHEA ), the US Food and Drug Administration (FDA) has had the authority to regulate dietary supplements; and, the FDA “plays an important role in helping consumers make use of safe, high-quality dietary supplements while also protecting Americans from the potential dangers of products that don’t meet the agency’s standards for marketing.”
In
The Business of Botanicals, author Ann Armbrecht follows the medicinal herb’s journey from seed to shelf, revealing the inner workings of a complicated industry, and raises questions about the ethical and ecological issues of mass production of medicines derived from these healing plants, many of which are imperiled in the wild.
From tulsi to turmeric, echinacea to elderberry, medicinal herbs are big business but do they deliver on their healing promise to those who consume them, those who provide them, and the natural world?
The following is an excerpt from
The Business of Botanicals by Ann Armbrecht. The excerpt was originally published on Literary Hub. It has been adapted for the web.
A bill that would protect hemp-derived CBD from the FDA needs our support. Action Alert (Article republished from ANH-USA.org) For a while now, we've been telling you about the FDA's [.]